← ANALYST RATINGS · TIPRANKS
Staar Surgical (STAA): analyst forecast and price target
Analyst consensus
Hold3 Buy4 Hold1 Sell
Ratings of 8 analysts in the last 3 months12-month forecast
Based on 8 price targets given in the last 3 months, the average target is $29.14, the highest $40.00, the lowest $20.00. The average is +37.0% from the last price of $21.27.
Analyst ratings 11
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $21.50 → $22.00+2.3% | Hold | +3.4% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $21.50 | Hold | +1.1% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $21.00 → $21.50+2.4% | Hold | +1.1% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $20.50 → $21.00+2.4% | Hold | −1.3% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $22.00 → $22.50+2.3% | Hold | +5.8% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $21.50 → $22.00+2.3% | Hold | +3.4% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| Thomas Stephan★★★★★★★★★★#3049 · hits 47% · avg +8.4% | Stifel Nicolaus | $28.00 → $31.00+10.7% | Buy | +45.7% | Upgrade | 29.09.26on TipRanks Sep 28 21:25 | +7.7%next day +1.0% · 5 days −3.2% | ↗ |
| John Young CFA★★★★★★★★★★#10305 · hits 40% · avg −2.8% | Canaccord Genuity | $32.00 | Buy | +50.4% | Reiterated | 24.09.26on TipRanks Sep 25 09:45 | −3.6%next day +7.0% · 5 days +17.7% | ↗ |
| Young Li★★★★★★★★★★#12189 · hits 16% · avg −26.1% | Jefferies | $28.00 → $23.00−17.9% | Hold | +8.1% | Reiterated | 22.09.26on TipRanks 08:35 | +1.6%next day −3.4% · 5 days +9.8% | ↗ |
| Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% | Piper Sandler | $33.00 | Hold | +55.1% | Reiterated | 13.08.26on TipRanks 07:10 | −1.0%next day +3.6% · 5 days −7.0% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | — | Hold | — | Reiterated | 13.08.26on TipRanks 06:55 | −1.0%next day +3.6% · 5 days −7.0% | ↗ |
| Simran Kaur | Wells Fargo | $25.00 | Hold | +17.5% | Assigned | 13.08.26on TipRanks 06:50 | −1.0%next day +3.6% · 5 days −7.0% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $20.00 | Sell | −6.0% | Initiated | 28.07.26on TipRanks Aug 2 21:04 | −1.5%next day +6.9% · 5 days +2.3% | ↗ |
| Michael Piccolo★★★★★★★★★★#9828 · hits 44% · avg −2.5% | Wedbush | $40.00 | Buy | +88.1% | Reiterated | 20.07.26on TipRanks Jul 25 21:02 | −9.2%next day +0.4% · 5 days −3.9% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | — | Hold | — | Reiterated | 16.07.26on TipRanks Jul 17 05:55 | +2.2%next day −7.8% · 5 days −14.9% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $22.00 → $27.00+22.7% | Hold | +26.9% | Reiterated | 14.05.26on TipRanks 07:30 | +8.1%next day +1.4% · 5 days +3.2% | ↗ |
| Unknown Analyst | Stephens | $28.00 | Hold | +31.6% | Reiterated | 04.03.26on TipRanks 07:40 | +0.9%next day −2.8% · 5 days −6.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Staar Surgical
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $29.14 at a price of $22.61 (+28.9%); now: $29.14 at $21.27 (+37.0%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 2 | 1 |
| Buy | 5 | 5 | 6 | 4 | 5 | 3 |
| Hold | 20 | 10 | 9 | 7 | 8 | 5 |
| Sell | 1 | 0 | 1 | 1 | 1 | 0 |
Earnings and sales forecast
Next report: 04.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.05 (from $-0.04 to $0.12). Last quarter: $0.16.
Sales
Next quarter’s sales estimate — $79M (from $73M to $85M). Last quarter: $94M.
Best top-analyst consensus in the sector · Healthcare
About Staar Surgical
- CEO: Warren Foust
- Employees: 921
- 25510 Commercentre Drive, Lake Forest, CA, 92630, US
- www.staar.com
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
Data from the stock’s TipRanks forecast page, read 114 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗